Wang Y, Ramachandran V, Sui D, Xu K, et al. Evaluation of Plasma Interleukin-6 in Melanoma Patients as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker. J Invest Dermatol 2021 Dec 21. pii: S0022-202X(21)02627.
PMID: 34952092